Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China flag China · Delayed Price · Currency is CNY
7.08
+0.16 (2.31%)
Apr 30, 2026, 3:00 PM CST

SHA:600351 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
2,1982,2402,6522,8802,6812,681
Other Revenue
--34.5229.4637.4583.2
2,1982,2402,6862,9102,7182,764
Revenue Growth (YoY)
-13.12%-16.60%-7.69%7.05%-1.66%6.21%
Cost of Revenue
1,0421,0641,3231,2461,2161,095
Gross Profit
1,1561,1761,3631,6641,5021,669
Selling, General & Admin
679.25697.86913.511,2281,1591,296
Research & Development
114.05117.27139.52118.29130.62157.13
Other Operating Expenses
9.9611.4331.3931.3433.9833.38
Operating Expenses
803.27826.561,0861,3731,3241,473
Operating Income
352.3349.71276.84291.5178.07196.65
Interest Expense
---5.35-12.3-18.77-22.61
Interest & Investment Income
74.3474.046.459.498.1822.04
Currency Exchange Gain (Loss)
--0.05-0.030.27-0.13
Other Non Operating Income (Expenses)
18.7315.15.96-9.75-8.01-3.53
EBT Excluding Unusual Items
445.37438.85283.95278.91159.74192.42
Impairment of Goodwill
-----48.3-
Gain (Loss) on Sale of Investments
4.4919-3.04-5.35-4.171.34
Gain (Loss) on Sale of Assets
0.160.180.351.120.120.15
Asset Writedown
-79.11-83.58-27.53-84.97-9.75-22.97
Other Unusual Items
--38.3729.2628.0230.66
Pretax Income
370.9374.46292.11218.98125.65201.59
Income Tax Expense
70.174.5668.1939.0721.0417.83
Earnings From Continuing Operations
300.8299.9223.92179.91104.6183.76
Minority Interest in Earnings
18.620.1118.7719.670.053.33
Net Income
319.41320.01242.69199.59104.66187.09
Net Income to Common
319.41320.01242.69199.59104.66187.09
Net Income Growth
34.38%31.86%21.60%90.71%-44.06%74.25%
Shares Outstanding (Basic)
696699723763770770
Shares Outstanding (Diluted)
696699723763770770
Shares Change (YoY)
-2.72%-3.29%-5.25%-0.89%0.02%-0.04%
EPS (Basic)
0.460.460.340.260.140.24
EPS (Diluted)
0.460.460.340.260.140.24
EPS Growth
38.14%36.35%28.34%92.42%-44.07%74.32%
Free Cash Flow
573.06524.91437.03397.7398.23342.45
Free Cash Flow Per Share
0.820.750.600.520.520.45
Dividend Per Share
--0.3000.1500.0500.080
Dividend Growth
--100.00%200.00%-37.50%60.00%
Gross Margin
52.58%52.51%50.73%57.19%55.27%60.39%
Operating Margin
16.03%15.61%10.31%10.02%6.55%7.12%
Profit Margin
14.54%14.29%9.04%6.86%3.85%6.77%
Free Cash Flow Margin
26.08%23.43%16.27%13.67%14.65%12.39%
EBITDA
485.88483.77412.82447.11338.04363.93
EBITDA Margin
22.11%21.60%15.37%15.37%12.44%13.17%
D&A For EBITDA
133.58134.06135.98155.61159.97167.27
EBIT
352.3349.71276.84291.5178.07196.65
EBIT Margin
16.03%15.61%10.31%10.02%6.55%7.12%
Effective Tax Rate
18.90%19.91%23.34%17.84%16.75%8.85%
Revenue as Reported
--2,6862,9102,7182,764
Advertising Expenses
--131.24119.31105.5100.49
Source: S&P Global Market Intelligence. Standard template. Financial Sources.